Skip to main content
. Author manuscript; available in PMC: 2016 Nov 21.
Published in final edited form as: J Antibiot (Tokyo). 2016 May 18;70(1):65–72. doi: 10.1038/ja.2016.52

Table 2.

MIC (µg/ml) of ampicillin-tetramic acid hybrids against gram-negative bacteria.

Compound AB EC ECΔtolC PV PM KP PA
ampicillin 100 3.13 3.13 100 3.13 100 >200
piperacillin 6.25 6.25 1.56 1.56 0.19 6.25 6.25
carbenicillin 100 100 0.09 100 1.56 50 100
1903 50 50 6.25 25 12.5 200 12.5
1905 200 25 6.25 50 25 200 25
1940 100 50 12.5 50 6.25 >200 25
2742 100 100 12.5 100 6.25 >200 25
2743 50 200 12.5 100 3.13 >200 25
2744 100 100 3.13 12.5 12.5 >200 25
2745 50 100 3.13 12.5 3.13 >200 25
2746 200 200 12.5 100 3.13 >200 50
2780 >200 200 6.25 12.5 1.56 >200 25
2781 50 100 3.13 6.25 3.13 >200 12.5
2782 25 25 1.56 12.5 12.5 >200 25
2833 25 100 3.13 100 6.25 200 25
2835 50 100 3.13 25 25 200 25
2916 50 50 1.56 6.25 6.25 >200 25
2917 50 12.5 6.25 6.25 3.1 >200 25
2918 100 6.25 6.25 6.25 6.25 >200 50
2919 25 12.5 3.13 25 50 200 50
3002 50 6.25 3.13 25 1.56 200 12.5

Key: AB= A. baumannii ATCC 19606; EC= E. coli BW25113; ECΔtolC= E. coli BW25113 ΔtolC derivative JW5503-1; PV= P. vulgaris ATCC 33420; PM= P. mirabilis ATCC 25933; KP= K. pneumoniae ATCC 13883; PA= P. aeruginosa PA01.